Explores how institutional investors should reconfigure portfolio allocations/strategies in a world of low returns.
Michael Cembalest analyzes the performance of over 6,700 domestic and international active equity managers, and discusses the challenges they face outperforming at a time of markets distorted by quantitative easing.
Armageddonists and the portfolio cost of fear, 2010-2019
An update from the front lines of the Trade War, with a focus on implications for investors
Eye on the Market: The Verdict
Michael discusses US-China trade war in context, the outlook for prescription drug price legislation, and an updated ideological scorecard for 2020 Presidential candidates.
Michael discusses how short covering, rather than real money, has driven the fastest recovery on record following a bear market, and looks ahead at slowing earnings growth.
The Fed halted tightening and propelled equities to their fastest recovery ever following a bear market. This decision was made despite the lowest unemployment rate in 40 years. Does that make sense? Also, a possible deal with China.
A close look at the Progressive Agenda, China’s deteriorating welcome mat in DC and US Tech IPOs.
Michael shares his thoughts on the US China trade war, Mexico tariffs and the US immigration policy.